Najam Sharif

Nanoscope Therapeutics Names VP of Global Research and Development

by | Oct 27, 2023

Najam Sharif, Ph.D., DSc, has been appointed as vice president of global research and development by Dallas-based Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases.

Sharif is a veteran in drug/device discovery and development, the company said.

“We are delighted to welcome Naj to the Nanoscope team,” Sulagna Bhattacharya, co-founder and CEO of Nanoscope, said in a statement....

MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.